Showing results (471-480 of 566) with videos related to

Sort By:
Pageof 57
Leukemia|July 8, 2005
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemiaM R Ricciardi, T McQueen, D Chism, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agentsW Zhang, M A Piatyszek, T Kobayashi, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 5, 1998
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cellsM W Wang, U Consoli, C M Lane, et al.
Leukemia|April 24, 1999
Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cellsH Engel, J Drach, A Keyhani, et al.
Leukemia & Lymphoma|March 1, 1996
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dlA Sarris, J Cortes, H Kantarjian, et al.
Blood|April 15, 1991
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaE Berman, G Heller, J Santorsa, et al.
Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.
Leukemia|October 29, 2011
Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitorsD H Mak, R-Y Wang, W D Schober, et al.
Experimental Hematology|June 1, 1992
Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemiaZ Estrov, E H Estey, M Andreeff, et al.
Blood|February 15, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemiaP Bettelheim, P Valent, M Andreeff, et al.
Pageof 57